CSI Market
Sign In | Register

Revance Therapeutics Inc (RVNC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RVNC Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Revance Therapeutics Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent58.59
Restricted Cash and Cash Equivalents, Current0.47
Short-term Investments, Total125.49
Cash & Short-term Investments183.00
Accounts receivable48.26
Inventories85.21
Disposal Group, Including Discontinued Operation, Assets, Current AS1.74
Prepaid Expense And Other Assets Current9.94
Total Current Assets329.69
Equipment/Property/Plant Net15.90
Intangible Assets7.63
Long-term investments5.56
Other Assets, Noncurrent58.00
Operating Lease Right Of Use Asset48.00
Total Assets461.56
Liabilities
Accounts Payable, Current AC12.34
Accrued Liabilities, Current AC34.02
Long-term Debt, Current Maturities LO10.15
Other Liabilities, Current23.54
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities80.05
Long-term debt421.04
Total Long-term Debt421.04
Other liabilities, Noncurrent123.50
Contract With Customer Liability Current6.33
Operating Lease Liability Current6.37
Contract With Customer Liability Noncurrent85.55
Total Liabilities624.59
Stockholders' Equity
Common Stock Value0.11
Additional Paid In Capital Common Stock2,043.89
Retained Earnings / Accumulated Deficit-2,207.10
Other Equity0.07
Common Stockholder's Equity-163.03
Total Stockholder's Equity-163.03
Liabilities & Stockholder's Equity461.56
4 historic quarters locked

Sign in to unlock the full Revance Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Revance Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001479290-24-000128

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.